Login / Signup

Within-Sulfonylurea-Class Evaluation of Time to Intensification with Insulin (ZODIAC-43).

Dennis SchrijndersLaura C HartogNanne KleefstraKlaas H GroenierGijs W D LandmanHenk J G Bilo
Published in: PloS one (2016)
In this large Dutch primary care cohort, new users of neither gliclazide, glimepiride nor tolbutamide as dual therapy with metformin, resulted in differences in the time needed for further treatment intensification.
Keyphrases
  • primary care
  • type diabetes
  • stem cells
  • metabolic syndrome
  • skeletal muscle
  • bone marrow
  • replacement therapy
  • insulin resistance